Telomere length and cardiovascular disease. 2010

Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
IFR Santé-STIC, UFR de Médecine et Pharmacie, Laboratoire de Physiopathologie et Pharmacologie Cardiovasculaires Expérimentales (LPPCE), Université de Bourgogne, 7, Boulevard Jeanne-d'Arc, 21000 Dijon, France. sebastien.saliques@gmail.com

Telomeres are structures composed of deoxyribonucleic acid repeats that protect the end of chromosomes, but shorten with each cell division. They have been the subject of many studies, particularly in the field of oncology, and more recently their role in the onset, development and prognosis of cardiovascular disease has generated considerable interest. It has already been shown that these structures may deteriorate at the beginning of the atherosclerotic process, in the onset and development of arterial hypertension or during myocardial infarction, in which their length may be a predictor of outcome. As telomere length by its nature is a marker of cell senescence, it is of particular interest when studying the lifespan and fate of endothelial cells and cardiomyocytes, especially so because telomere length seems to be regulated by various factors notably certain cardiovascular risk factors, such as smoking, sex and obesity that are associated with high levels of oxidative stress. To gain insights into the links between telomere length and cardiovascular disease, and to assess the usefulness of telomere length as a new marker of cardiovascular risk, it seems essential to review the considerable amount of data published recently on the subject.

UI MeSH Term Description Entries
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016615 Telomere A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs. Telomeres
D016922 Cellular Senescence Process by which cells irreversibly stop dividing and enter a state of permanent growth arrest without undergoing CELL DEATH. Senescence can be induced by DNA DAMAGE or other cellular stresses, such as OXIDATIVE STRESS. Aging, Cell,Cell Aging,Cell Senescence,Replicative Senescence,Senescence, Cellular,Senescence, Replicative,Cell Ageing,Cellular Ageing,Cellular Aging,Ageing, Cell,Ageing, Cellular,Aging, Cellular,Senescence, Cell
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative
D032383 Myocytes, Cardiac Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC). Cardiomyocytes,Muscle Cells, Cardiac,Muscle Cells, Heart,Cardiac Muscle Cell,Cardiac Muscle Cells,Cardiac Myocyte,Cardiac Myocytes,Cardiomyocyte,Cell, Cardiac Muscle,Cell, Heart Muscle,Cells, Cardiac Muscle,Cells, Heart Muscle,Heart Muscle Cell,Heart Muscle Cells,Muscle Cell, Cardiac,Muscle Cell, Heart,Myocyte, Cardiac

Related Publications

Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
July 2014, BMJ (Clinical research ed.),
Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
May 2019, Current opinion in cardiology,
Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
July 2017, Journal of the American College of Cardiology,
Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
June 2012, Annals of medicine,
Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
January 2007, American journal of epidemiology,
Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
October 2015, Kardiologiia,
Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
May 2019, Biomolecules,
Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
January 2007, Lancet (London, England),
Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
October 2018, JACC. Basic to translational science,
Sébastien Saliques, and Marianne Zeller, and Julie Lorin, and Luc Lorgis, and Jean-Raymond Teyssier, and Yves Cottin, and Luc Rochette, and Catherine Vergely
November 2011, Future cardiology,
Copied contents to your clipboard!